Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Analysis of the geographical accessibility of vape shops in the vicinity of Quebec's secondary and college educational institutions.

Robitaille É, Bergeron P, Houde M.

Health Promot Chronic Dis Prev Can. 2019 Sep;39(8-9):235-243. doi: 10.24095/hpcdp.39.8/9.01. English, French.

PMID:
31517466
2.

Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain.

McKerrall SJ, Nguyen T, Lai KW, Bergeron P, Deng L, DiPasquale A, Chang JH, Chen J, Chernov-Rogan T, Hackos DH, Maher J, Ortwine DF, Pang J, Payandeh J, Proctor WR, Shields SD, Vogt J, Ji P, Liu W, Ballini E, Schumann L, Tarozzo G, Bankar G, Chowdhury S, Hasan A, Johnson JP Jr, Khakh K, Lin S, Cohen CJ, Dehnhardt CM, Safina BS, Sutherlin DP.

J Med Chem. 2019 Apr 25;62(8):4091-4109. doi: 10.1021/acs.jmedchem.9b00141. Epub 2019 Apr 16.

PMID:
30943032
3.

Using Geographic Distance as a Potential Proxy for Help in the Assessment of the Grandmother Hypothesis.

Engelhardt SC, Bergeron P, Gagnon A, Dillon L, Pelletier F.

Curr Biol. 2019 Feb 18;29(4):651-656.e3. doi: 10.1016/j.cub.2019.01.027. Epub 2019 Feb 7.

PMID:
30744976
4.

Development of small blood volume assays for the measurement of oxidative stress markers in mammals.

Langille E, Lemieux V, Garant D, Bergeron P.

PLoS One. 2018 Dec 27;13(12):e0209802. doi: 10.1371/journal.pone.0209802. eCollection 2018.

5.

A large oxygen-dominated core from the seismic cartography of a pulsating white dwarf.

Giammichele N, Charpinet S, Fontaine G, Brassard P, Green EM, Van Grootel V, Bergeron P, Zong W, Dupret MA.

Nature. 2018 Feb 1;554(7690):73-76. doi: 10.1038/nature25136. Epub 2018 Jan 8.

6.

Why and How Political Science Can Contribute to Public Health? Proposals for Collaborative Research Avenues.

Gagnon F, Bergeron P, Clavier C, Fafard P, Martin E, Blouin C.

Int J Health Policy Manag. 2017 Apr 5;6(9):495-499. doi: 10.15171/ijhpm.2017.38.

7.

Field estimates of parentage reveal sexually antagonistic selection on body size in a population of Anolis lizards.

Duryea MC, Bergeron P, Clare-Salzler Z, Calsbeek R.

Ecol Evol. 2016 Sep 9;6(19):7024-7031. doi: 10.1002/ece3.2443. eCollection 2016 Oct.

8.

Eco-evolutionary dynamics in a contemporary human population.

Pelletier F, Pigeon G, Bergeron P, Mayer FM, Boisvert M, Réale D, Milot E.

Nat Commun. 2017 Jul 4;8:15947. doi: 10.1038/ncomms15947.

9.

Relativistic deflection of background starlight measures the mass of a nearby white dwarf star.

Sahu KC, Anderson J, Casertano S, Bond HE, Bergeron P, Nelan EP, Pueyo L, Brown TM, Bellini A, Levay ZG, Sokol J, Dominik M, Calamida A, Kains N, Livio M.

Science. 2017 Jun 9;356(6342):1046-1050. doi: 10.1126/science.aal2879. Epub 2017 Jun 7.

PMID:
28592430
10.

The University-Public Health Partnership for Public Health Research Training in Quebec, Canada.

Paradis G, Hamelin AM, Malowany M, Levy J, Rossignol M, Bergeron P, Kishchuk N.

Am J Public Health. 2017 Jan;107(1):100-104. Epub 2016 Nov 17.

11.

Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 Mutations.

Johnson AR, Kohli PB, Katewa A, Gogol E, Belmont LD, Choy R, Penuel E, Burton L, Eigenbrot C, Yu C, Ortwine DF, Bowman K, Franke Y, Tam C, Estevez A, Mortara K, Wu J, Li H, Lin M, Bergeron P, Crawford JJ, Young WB.

ACS Chem Biol. 2016 Oct 21;11(10):2897-2907. Epub 2016 Sep 7.

PMID:
27571029
12.

Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8.

Bergeron P, Koehler MF, Blackwood EM, Bowman K, Clark K, Firestein R, Kiefer JR, Maskos K, McCleland ML, Orren L, Ramaswamy S, Salphati L, Schmidt S, Schneider EV, Wu J, Beresini M.

ACS Med Chem Lett. 2016 Apr 5;7(6):595-600. doi: 10.1021/acsmedchemlett.6b00044. eCollection 2016 Jun 9.

13.

Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells.

Koehler MF, Bergeron P, Blackwood EM, Bowman K, Clark KR, Firestein R, Kiefer JR, Maskos K, McCleland ML, Orren L, Salphati L, Schmidt S, Schneider EV, Wu J, Beresini MH.

ACS Med Chem Lett. 2016 Jan 6;7(3):223-8. doi: 10.1021/acsmedchemlett.5b00278. eCollection 2016 Mar 10.

14.

Association between Floods and Acute Cardiovascular Diseases: A Population-Based Cohort Study Using a Geographic Information System Approach.

Vanasse A, Cohen A, Courteau J, Bergeron P, Dault R, Gosselin P, Blais C, Bélanger D, Rochette L, Chebana F.

Int J Environ Res Public Health. 2016 Jan 28;13(2):168. doi: 10.3390/ijerph13020168.

15.

Extensive Surgical Treatment of Primary Pulmonary Synovial Sarcoma After Recurrent Pneumothorax.

Petrosyan A, Bergeron P.

Ann Thorac Surg. 2015 Nov;100(5):1893-5. doi: 10.1016/j.athoracsur.2014.12.092.

PMID:
26522536
16.
17.

Homeostatic dysregulation proceeds in parallel in multiple physiological systems.

Li Q, Wang S, Milot E, Bergeron P, Ferrucci L, Fried LP, Cohen AA.

Aging Cell. 2015 Dec;14(6):1103-12. doi: 10.1111/acel.12402. Epub 2015 Sep 29.

18.

Intralocus sexual conflict, adaptive sex allocation, and the heritability of fitness.

Calsbeek R, Duryea MC, Goedert D, Bergeron P, Cox RM.

J Evol Biol. 2015 Nov;28(11):1975-85. doi: 10.1111/jeb.12713. Epub 2015 Aug 27.

19.

An integrated suite of modeling tools that empower scientists in structure- and property-based drug design.

Feng JA, Aliagas I, Bergeron P, Blaney JM, Bradley EK, Koehler MF, Lee ML, Ortwine DF, Tsui V, Wu J, Gobbi A.

J Comput Aided Mol Des. 2015 Jun;29(6):511-23. doi: 10.1007/s10822-015-9845-4. Epub 2015 Apr 29.

PMID:
25921252
20.

Neighbourhood immigration, health care utilization and outcomes in patients with diabetes living in the Montreal metropolitan area (Canada): a population health perspective.

Vanasse A, Courteau J, Orzanco MG, Bergeron P, Cohen AA, Niyonsenga T.

BMC Health Serv Res. 2015 Apr 9;15:146. doi: 10.1186/s12913-015-0824-1.

21.

Direct percutaneous carotid access for carotid angioplasty and stenting.

Bergeron P.

J Endovasc Ther. 2015 Feb;22(1):135-8. doi: 10.1177/1526602814564362.

PMID:
25775694
22.

Detection of a novel, integrative aging process suggests complex physiological integration.

Cohen AA, Milot E, Li Q, Bergeron P, Poirier R, Dusseault-Bélanger F, Fülöp T, Leroux M, Legault V, Metter EJ, Fried LP, Ferrucci L.

PLoS One. 2015 Mar 11;10(3):e0116489. doi: 10.1371/journal.pone.0116489. eCollection 2015.

23.

Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL.

Koehler MF, Bergeron P, Choo EF, Lau K, Ndubaku C, Dudley D, Gibbons P, Sleebs BE, Rye CS, Nikolakopoulos G, Bui C, Kulasegaram S, Kersten WJ, Smith BJ, Czabotar PE, Colman PM, Huang DC, Baell JB, Watson KG, Hasvold L, Tao ZF, Wang L, Souers AJ, Elmore SW, Flygare JA, Fairbrother WJ, Lessene G.

ACS Med Chem Lett. 2014 Mar 21;5(6):662-7. doi: 10.1021/ml500030p. eCollection 2014 Jun 12.

24.

Methodological issues in analyzing small populations using CCHS cycles based on the official language minority studies.

Makvandi E, Bouchard L, Bergeron PJ, Sedigh G.

Can J Public Health. 2013 Jun 13;104(6 Suppl 1):S55-9.

PMID:
24300323
25.

Pulsed resources and the coupling between life-history strategies and exploration patterns in eastern chipmunks (Tamias striatus).

Montiglio PO, Garant D, Bergeron P, Messier GD, Réale D.

J Anim Ecol. 2014 May;83(3):720-8. doi: 10.1111/1365-2656.12174. Epub 2014 Jan 6.

PMID:
24180283
26.

A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors.

Lee W, Ortwine DF, Bergeron P, Lau K, Lin L, Malek S, Nonomiya J, Pei Z, Robarge KD, Schmidt S, Sideris S, Lyssikatos JP.

Bioorg Med Chem Lett. 2013 Sep 15;23(18):5097-104. doi: 10.1016/j.bmcl.2013.07.027. Epub 2013 Jul 23.

PMID:
23932790
27.

Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2.

Zak M, Hurley CA, Ward SI, Bergeron P, Barrett K, Balazs M, Blair WS, Bull R, Chakravarty P, Chang C, Crackett P, Deshmukh G, DeVoss J, Dragovich PS, Eigenbrot C, Ellwood C, Gaines S, Ghilardi N, Gibbons P, Gradl S, Gribling P, Hamman C, Harstad E, Hewitt P, Johnson A, Johnson T, Kenny JR, Koehler MF, Bir Kohli P, Labadie S, Lee WP, Liao J, Liimatta M, Mendonca R, Narukulla R, Pulk R, Reeve A, Savage S, Shia S, Steffek M, Ubhayakar S, van Abbema A, Aliagas I, Avitabile-Woo B, Xiao Y, Yang J, Kulagowski JJ.

J Med Chem. 2013 Jun 13;56(11):4764-85. doi: 10.1021/jm4004895. Epub 2013 May 31.

PMID:
23659214
28.

Comment on "Bateman in nature: predation on offspring reduces the potential for sexual selection".

Bergeron P, Martin AM, Garant D, Pelletier F.

Science. 2013 May 3;340(6132):549. doi: 10.1126/science.1233246.

29.

Disruptive viability selection on adult exploratory behaviour in eastern chipmunks.

Bergeron P, Montiglio PO, Réale D, Humphries MM, Gimenez O, Garant D.

J Evol Biol. 2013 Apr;26(4):766-74. doi: 10.1111/jeb.12081. Epub 2013 Feb 25.

30.

Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349.

Pei Z, Blackwood E, Liu L, Malek S, Belvin M, Koehler MF, Ortwine DF, Chen H, Cohen F, Kenny JR, Bergeron P, Lau K, Ly C, Zhao X, Estrada AA, Truong T, Epler JA, Nonomiya J, Trinh L, Sideris S, Lesnick J, Bao L, Vijapurkar U, Mukadam S, Tay S, Deshmukh G, Chen YH, Ding X, Friedman LS, Lyssikatos JP.

ACS Med Chem Lett. 2012 Nov 29;4(1):103-7. doi: 10.1021/ml3003132. eCollection 2013 Jan 10.

31.

Potent, selective, and orally bioavailable inhibitors of the mammalian target of rapamycin kinase domain exhibiting single agent antiproliferative activity.

Koehler MF, Bergeron P, Blackwood E, Bowman KK, Chen YH, Deshmukh G, Ding X, Epler J, Lau K, Lee L, Liu L, Ly C, Malek S, Nonomiya J, Oeh J, Ortwine DF, Sampath D, Sideris S, Trinh L, Truong T, Wu J, Pei Z, Lyssikatos JP.

J Med Chem. 2012 Dec 27;55(24):10958-71. doi: 10.1021/jm301389h. Epub 2012 Dec 12.

PMID:
23199076
32.

Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2.

Labadie S, Dragovich PS, Barrett K, Blair WS, Bergeron P, Chang C, Deshmukh G, Eigenbrot C, Ghilardi N, Gibbons P, Hurley CA, Johnson A, Kenny JR, Kohli PB, Kulagowski JJ, Liimatta M, Lupardus PJ, Mendonca R, Murray JM, Pulk R, Shia S, Steffek M, Ubhayakar S, Ultsch M, van Abbema A, Ward S, Zak M.

Bioorg Med Chem Lett. 2012 Dec 15;22(24):7627-33. doi: 10.1016/j.bmcl.2012.10.008. Epub 2012 Oct 11.

PMID:
23107482
33.

Environmental conditions affect spatial genetic structures and dispersal patterns in a solitary rodent.

Messier GD, Garant D, Bergeron P, Réale D.

Mol Ecol. 2012 Nov;21(21):5363-73. doi: 10.1111/mec.12022. Epub 2012 Sep 27.

PMID:
23017101
34.

[Training in knowledge translation from the view of the learner].

Besner F, Laurendeau MC, Bergeron P.

Can J Public Health. 2012 May-Jun;103(3):235-7. French.

PMID:
22905646
35.

Hybrid repair with antegrade visceral artery debranching: the preferred treatment option for thoracoabdominal aneurysms in high-risk patients.

Markatis F, Petrosyan A, Abdulamit T, Bergeron P.

J Endovasc Ther. 2012 Jun;19(3):356-62. doi: 10.1583/11-3735MR.1.

PMID:
22788887
36.

Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2.

Zak M, Mendonca R, Balazs M, Barrett K, Bergeron P, Blair WS, Chang C, Deshmukh G, Devoss J, Dragovich PS, Eigenbrot C, Ghilardi N, Gibbons P, Gradl S, Hamman C, Hanan EJ, Harstad E, Hewitt PR, Hurley CA, Jin T, Johnson A, Johnson T, Kenny JR, Koehler MF, Bir Kohli P, Kulagowski JJ, Labadie S, Liao J, Liimatta M, Lin Z, Lupardus PJ, Maxey RJ, Murray JM, Pulk R, Rodriguez M, Savage S, Shia S, Steffek M, Ubhayakar S, Ultsch M, van Abbema A, Ward SI, Xiao L, Xiao Y.

J Med Chem. 2012 Jul 12;55(13):6176-93. doi: 10.1021/jm300628c. Epub 2012 Jun 28.

PMID:
22698084
37.

Aortic debranching from the ascending aorta: a novel surgical approach for extended TAAA and chronic type B dissections in high risk patients.

Abdulamit T, Mangialardi N, Petrosyan A, Costa P, Albrand JJ, Trastour JC, Bergeron P.

J Cardiovasc Surg (Torino). 2012 Jun;53(3):345-53.

PMID:
22695267
38.

The energetic and survival costs of growth in free-ranging chipmunks.

Careau V, Bergeron P, Garant D, Réale D, Speakman JR, Humphries MM.

Oecologia. 2013 Jan;171(1):11-23. doi: 10.1007/s00442-012-2385-x. Epub 2012 Jun 13.

PMID:
22692385
39.

Acute carotid stent thrombosis: a case of surgical revascularization and review of treatment options.

Markatis F, Petrosyan A, Abdulamit T, Bergeron P.

Vascular. 2012 Aug;20(4):217-20. doi: 10.1258/vasc.2011.cr0303. Epub 2012 May 10. Review.

PMID:
22577161
40.

Anticipation and tracking of pulsed resources drive population dynamics in eastern chipmunks.

Bergeron P, Réale D, Humphries MM, Garant D.

Ecology. 2011 Nov;92(11):2027-34.

PMID:
22164826
41.

Rapid monitoring of Escherichia coli and Enterococcus spp. in bathing water using reverse transcription-quantitative PCR.

Bergeron P, Oujati H, Catalán Cuenca V, Huguet Mestre JM, Courtois S.

Int J Hyg Environ Health. 2011 Nov;214(6):478-84. doi: 10.1016/j.ijheh.2011.07.013. Epub 2011 Sep 13.

PMID:
21917514
43.

Evidence of multiple paternity and mate selection for inbreeding avoidance in wild eastern chipmunks.

Bergeron P, Réale D, Humphries MM, Garant D.

J Evol Biol. 2011 Aug;24(8):1685-94. doi: 10.1111/j.1420-9101.2011.02294.x. Epub 2011 May 17.

44.

Potent, selective, and orally bioavailable inhibitors of mammalian target of rapamycin (mTOR) kinase based on a quaternary substituted dihydrofuropyrimidine.

Cohen F, Bergeron P, Blackwood E, Bowman KK, Chen H, Dipasquale AG, Epler JA, Koehler MF, Lau K, Lewis C, Liu L, Ly CQ, Malek S, Nonomiya J, Ortwine DF, Pei Z, Robarge KD, Sideris S, Trinh L, Truong T, Wu J, Zhao X, Lyssikatos JP.

J Med Chem. 2011 May 12;54(9):3426-35. doi: 10.1021/jm200215y. Epub 2011 Apr 15.

PMID:
21495671
45.

Information in the sample covariate distribution in prevalent cohorts.

Cook RJ, Bergeron PJ.

Stat Med. 2011 May 30;30(12):1397-409. doi: 10.1002/sim.4180. Epub 2011 Jan 23. Erratum in: Stat Med. 2011 Nov 20;30(26):3166.

PMID:
21259303
46.

Personality and the emergence of the pace-of-life syndrome concept at the population level.

Réale D, Garant D, Humphries MM, Bergeron P, Careau V, Montiglio PO.

Philos Trans R Soc Lond B Biol Sci. 2010 Dec 27;365(1560):4051-63. doi: 10.1098/rstb.2010.0208. Review.

47.

Individual quality: tautology or biological reality?

Bergeron P, Baeta R, Pelletier F, Réale D, Garant D.

J Anim Ecol. 2011 Mar;80(2):361-4. doi: 10.1111/j.1365-2656.2010.01770.x. Epub 2010 Nov 4. No abstract available.

PMID:
21054382
48.

Staged hybrid repair of thoracoabdominal aortic aneurysm after chronic type B aortic dissection.

Mangialardi N, Costa P, Bergeron P, Serrao E, Ronchey S.

Vascular. 2010 Nov-Dec;18(6):336-43.

PMID:
20979921
49.

Antagonists of inhibitor of apoptosis proteins based on thiazole amide isosteres.

Cohen F, Koehler MF, Bergeron P, Elliott LO, Flygare JA, Franklin MC, Gazzard L, Keteltas SF, Lau K, Ly CQ, Tsui V, Fairbrother WJ.

Bioorg Med Chem Lett. 2010 Apr 1;20(7):2229-33. doi: 10.1016/j.bmcl.2010.02.021. Epub 2010 Feb 8. Erratum in: Bioorg Med Chem Lett. 2012 Jan 1;22(1):753-4.

PMID:
20189383
50.

Retrograde type A aortic dissections after endovascular stent-graft placement for type B dissection.

Bellos JK, Petrosyan A, Abdulamit T, Trastour JC, Bergeron P.

J Cardiovasc Surg (Torino). 2010 Feb;51(1):85-93. Review.

PMID:
20081764

Supplemental Content

Loading ...
Support Center